Pregnancy, progesterone and progestins in relation to breast cancer risk.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Journal of Steroid Biochemistry and Molecular Biology

• Publication date

  2005-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.JSBMB.2005.08.015PMID 16249080
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Progesterone Treatment to Prevent Preterm Birth

  2012cited by this paper
• Breast cancer risk in relation to different types of hormone replacement therapy in the E3N‐EPIC cohort

  2005cited by this paper
• Progestational Agents to Prevent Preterm Birth: A Meta-Analysis of Randomized Controlled Trials

  2005cited by this paper
• Progestins and progesterone in hormone replacement therapy and the risk of breast cancer.

  2005cited by this paper
• Serum concentrations of IGF‐I, IGFBP‐3 and c‐peptide and risk of hyperplasia and cancer of the breast in postmenopausal women

  2004cited by this paper
• National cross sectional survey to determine whether the decision to delivery interval is critical in emergency caesarean section

  2004cited by this paper
• Serum levels of leptin, insulin-like growth factor-I and insulin-like growth factor binding protein-3 in women with pre-eclampsia, and their relationship to insulin resistance

  2004cited by this paper
• The relationship between plasma levels of leptin and androgen in healthy and preeclamptic pregnant women

  2004cited by this paper
• Genotoxicity of steroidal estrogens.

  2004cited by this paper
• Maternal plasma and amniotic fluid 17β-estradiol, progesterone and cortisol concentrations in women with successfully and unsuccessfully treated preterm labor

  2004cited by this paper
• Can Serum HCG Values Be Used in the Differential Diagnosis of Pregnancy Complicated by Hypertension?

  2004cited by this paper
• IGF‐I and breast cancer: A meta‐analysis

  2004cited by this paper
• Endogenous sex hormones and subsequent breast cancer in premenopausal women

  2004cited by this paper
• Increased risk of breast cancer following different regimens of hormone replacement therapy frequently used in Europe

  2004cited by this paper
• Impact of reproductive factors and lactation on breast carcinoma in situ risk

  2004cited by this paper
• Breast Cancer

  2004cited by this paper
• Androgen levels in pre‐eclamptic pregnant women

  2004cited by this paper
• Null association between pregnancy termination and breast cancer in a registry‐based study of parous women

  2004cited by this paper
• Insulin‐like growth factor (IGF)‐I and IGF‐binding protein 3 and the risk of premenopausal breast cancer: A meta‐analysis of literature

  2004cited by this paper
• Human breast cell proliferation and its relationship to steroid receptor expression

  2004cited by this paper
• Development of the human breast.

  2004cited by this paper
• First pregnancy characteristics and subsequent breast cancer risk among young women

  2004influential reference
• Hot Papers in the Literature

  2004cited by this paper
• Progesterone Treatment to Prevent Preterm Birth

  2004cited by this paper
• Hyperinsulinaemia and Increased Risk of Breast Cancer: Findings From the British Women's Heart and Health Study

  2004cited by this paper
• Serum levels of insulin, IGF‐1, and IGFBP‐1 in pre‐eclampsia and eclampsia

  2004cited by this paper
• Maternal serum oestrogen and androgen concentrations in preeclamptic and uncomplicated pregnancies.

  2003cited by this paper
• Pregnancy hormones, pre-eclampsia, and implications for breast cancer risk in the offspring.

  2003cited by this paper
• Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial.

  2003cited by this paper
• Effects of dietary intervention on IGF-I and IGF-binding proteins, and related alterations in sex steroid metabolism: the Diet and Androgens (DIANA) Randomised Trial

  2003cited by this paper
• A prospective study of different types of hormone replacement therapy use and the risk of subsequent breast cancer: the women's health in the Lund area (WHILA) study (Sweden)

  2003cited by this paper
• Differential effects of progestins on breast tissue enzymes.

  2003cited by this paper
• Interactions between estrogen and insulin-like growth factor signaling pathways in human breast tumor cells.

  2003cited by this paper
• Maternal serum activin, inhibin, human chorionic gonadotrophin and α‐fetoprotein as second trimester predictors of pre‐eclampsia

  2003cited by this paper
• Induced and spontaneous abortion and breast cancer risk: Results from the E3N cohort study

  2003cited by this paper
• Hormone replacement therapy and risk of breast cancer: the role of progestins

  2003cited by this paper
• Differential effects of progestins on the circulating IGF-I system.

  2003cited by this paper
• Classification and pharmacology of progestins.

  2003cited by this paper
• Modulation by progestogens of the effects of oestrogen on hepatic endocrine function in postmenopausal women

  2003cited by this paper
• Midtrimester triple test levels in women with severe preeclampsia and HELLP syndrome

  2003cited by this paper
• Breast cancer and hormone-replacement therapy in the Million Women Study.

  2003cited by this paper
• IARC Handbooks of Cancer prevention

  2003cited by this paper
• Nutrition and Lifestyle: Opportunities for Cancer Prevention

  2003cited by this paper
• Influence of Estrogen Plus Progestin on Breast Cancer and Mammography in Healthy Postmenopausal Women: The Women's Health Initiative Randomized Trial

  2003cited by this paper
• Breast cancer and hormone-replacement therapy in the Million Women Study.

  2003cited by this paper
• 17β-Estradiol is carcinogenic in human breast epithelial cells

  2002cited by this paper
• Steroid hormone levels during pregnancy and incidence of maternal breast cancer.

  2002influential reference
• Pregnancy related protection against breast cancer depends on length of gestation

  2002cited by this paper
• Pre-eclampsia in pregnancy and subsequent risk for breast cancer

  2002cited by this paper
• Alpha-foetoprotein in umbilical cord in relation to severe pre-eclampsia, birth weight and future breast cancer risk

  2002cited by this paper
• Prospective study of IGF-I, IGF-binding proteins, and breast cancer risk, in Northern and Southern Sweden

  2002cited by this paper
• DIANA trials on diet and endogenous hormones.

  2002cited by this paper
• Positive effects on cardiovascular and breast metabolic markers of oral estradiol and dydrogesterone in comparison with transdermal estradiol and norethisterone acetate.

  2002cited by this paper
• Noncardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II).

  2002cited by this paper
• 17Beta-estradiol is carcinogenic in human breast epithelial cells.

  2002cited by this paper
• Breast cancer: Prognosis, Treatment and Prevention Published in July 2002 by Marcel Dekker Inc., New York, USA; Basel, Switzerland; 656 pages; ISBN: 0-8247-0712-5; US$ 165.00

  2002cited by this paper
• Noncardiovascular disease outcomes during 6.8 years of hormone therapy : Heart and Estrogen/Progestin Study fellow-up (HERS II)

  2002cited by this paper
• Postmenopausal estrogen and progestin use in relation to breast cancer risk.

  2002cited by this paper
• Fasting glucose is a risk factor for breast cancer: a prospective study.

  2002cited by this paper
• Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II).

  2002cited by this paper
• Effects of progestogens on the postmenopausal breast

  2002cited by this paper
• Placental characteristics and reduced risk of maternal breast cancer.

  2001cited by this paper
• Energy balance and cancer: the role of insulin and insulin-like growth factor-I

  2001cited by this paper
• Risk of breast cancer with progestins in combination with estrogen as hormone replacement therapy.

  2001cited by this paper
• Progestins and menopause: epidemiological studies of risks of endometrial and breast cancer.

  2000cited by this paper
• Risk of breast cancer in prematurely born women.

  2000cited by this paper
• Progestins abrogate estrogen-induced changes in the insulin-like growth factor axis.

  2000cited by this paper
• Mean arterial pressure, pregnancy-induced hypertension, and preeclampsia: evaluation as independent risk factors and as surrogates for high maternal serum alpha-fetoprotein in estimating breast cancer risk.

  2000cited by this paper
• Effects of oral and transdermal 17beta-estradiol with cyclical oral norethindrone acetate on insulin sensitivity, secretion, and elimination in postmenopausal women.

  2000cited by this paper
• Induction of estrogen receptor-α and -β activities by synthetic progestins

  2000cited by this paper
• Induction of estrogen receptor-alpha and -beta activities by synthetic progestins.

  2000cited by this paper
• Sex hormone-binding globulin, its membrane receptor, and breast cancer: a new approach to the modulation of estradiol action in neoplastic cells.

  1999cited by this paper
• Long-term effects of oral estradiol and dydrogesterone on carbohydrate metabolism in postmenopausal women.

  1999cited by this paper
• Two centuries of mortality in ten large families with Huntington disease: a rising impact of gene carriership.

  1999cited by this paper
• Sex Hormone-Binding Globulin and Breast Cancer Risk

  1999cited by this paper
• Breast‐cancer risk following long‐term oestrogen‐ and oestrogen‐progestin‐replacement therapy

  1999cited by this paper
• Hypothesis: Progesterone primes breast cancer cells for cross-talk with proliferative or antiproliferative signals.

  1999cited by this paper
• Preeclampsia and breast cancer risk.

  1999influential reference
• Androgen receptor agonist activity of the synthetic progestin, medroxyprogesterone acetate, in human breast cancer cells.

  1999cited by this paper
• Preterm delivery and risk of breast cancer

  1999cited by this paper
• Estradiol and progesterone regulate the proliferation of human breast epithelial cells.

  1998cited by this paper
• Pregnancy Characteristics and Maternal Risk of Breast Cancer

  1998cited by this paper
• Biphasic regulation of breast cancer cell growth by progesterone: role of the cyclin-dependent kinase inhibitors, p21 and p27(Kip1).

  1997cited by this paper
• Estrogen replacement therapy decreases hyperandrogenicity and improves glucose homeostasis and plasma lipids in postmenopausal women with noninsulin-dependent diabetes mellitus.

  1997cited by this paper
• Intrauterine environment and breast cancer risk in women: a population-based study.

  1997cited by this paper
• Nutrition, hormones, and breast cancer: Is insulin the missing link?

  1996cited by this paper
• The androgenicity of progestins.

  1995cited by this paper
• The etiopathogenesis of breast cancer prevention.

  1995cited by this paper
• THE METABOLIC AND CARDIOVASCULAR CONSEQUENCES OF HRT

  1995cited by this paper
• Potential impact on breast cancer risk of circulating insulin-like growth factor I modifications induced by oral HRT in menopause.

  1995cited by this paper
• The proliferation of normal human breast tissue implanted into athymic nude mice is stimulated by estrogen but not progesterone.

  1995cited by this paper
• Human preterm birth is associated with systemic and local changes in progesterone/17 beta-estradiol ratios.

  1994cited by this paper
• Androgenic progestogens oppose the decrease of insulin-like growth factor I serum level induced by conjugated oestrogens in postmenopausal women. Preliminary report.

  1994cited by this paper
• Role of insulin-like growth factors in steroid modulated proliferation.

  1994cited by this paper
• Nutritional regulation of the insulin-like growth factors.

  1994cited by this paper
• Insulin resistance, secretion, and elimination in postmenopausal women receiving oral or transdermal hormone replacement therapy.

  1993cited by this paper
• A possible bimodal effect of estrogen on insulin sensitivity in postmenopausal women and the attenuating effect of added progestin.

  1993cited by this paper
• Hormone replacement therapy alters insulin sensitivity in young women with premature ovarian failure.

  1993cited by this paper
• Intrinsic estrogenicity of some progestagenic drugs.

  1992cited by this paper
• Insulin resistance and breast‐cancer risk

  1992cited by this paper

• Association of physical weight statuses defined by body mass index (BMI) with molecular subtypes of premenopausal breast cancer: a systematic review and meta-analysis

  2023cites this paper
• Association of genetic polymorphisms with local steroid metabolism in human benign breasts.

  2021cites this paper
• Interactions between benzophenone-3 and dietary fat in mammary tumorigenesis

  2020cites this paper
• Benzophenone-3 promotion of mammary tumorigenesis is diet-dependent

  2020cites this paper
• Obesity, Leptin and Breast Cancer: Epidemiological Evidence and Proposed Mechanisms

  2019cites this paper
• Leptin induces cell migration and invasion in a FAK-Src-dependent manner in breast cancer cells

  2019cites this paper
• Obesity and breast cancer in premenopausal women: Current evidence and future perspectives.

  2018cites this paper
• Effect of Oestrogen Exposure, Obesity, Exercise and Diet on Breast Cancer Risk

  2018cites this paper
• Progesterone regulation of tissue factor depends on MEK1/2 activation and requires the proline-rich site on progesterone receptor

  2015cites this paper
• HRT optimization, using transdermal estradiol plus micronized progesterone, a safer HRT

  2013cites this paper
• Risk of Breast Cancer by Type of Menopausal Hormone Therapy: a Case-Control Study among Post-Menopausal Women in France

  2013cites this paper
• Protective Effect of Progesterone during Pregnancy against Ovarian Cancer

  2013cites this paper
• Estrogen treatment affects brain functioning after menopause

  2011cites this paper
• Menopausal hormone therapy and breast cancer risk: Impact of different treatments. The European Prospective Investigation into Cancer and Nutrition

  2011cites this paper
• Benefits and risks of ovarian function and reproduction for cancer development and prevention

  2011cites this paper
• Sex hormone therapy and functional brain plasticity in postmenopausal women.

  2011cites this paper
• Effects of different progestogens on human breast tumor cell growth

  2011cites this paper
• ALUE APOPTOSIS IN OVARIAN TO DEVELOPMENT OF SOME DISEASES OF REPRODUCTIVE SYSTEM

  2011cites this paper
• Etude du facteur de transcription précoce EGR1 dans l'effet anti-prolifératif des ligands de PPARgamma sur les cellules cancéreuses mammaires

  2011cites this paper
• INTERNATIONAL HEALTH NEWS

  2010cites this paper
• Pregnancy characteristics and maternal breast cancer risk: a review of the epidemiologic literature

  2010influential citation
• t he Bioidentical Hormone Debate: a re Bioidentical Hormones ( e stradiol, e striol, and Progesterone) s afer or More e fficacious than Commonly u sed s ynthetic Versions in Hormone r eplacement t herapy?

  2009cites this paper
• Effects of sex hormone therapy on interhemispheric crosstalk in postmenopausal women.

  2009cites this paper
• The Bioidentical Hormone Debate: Are Bioidentical Hormones (Estradiol, Estriol, and Progesterone) Safer or More Efficacious than Commonly Used Synthetic Versions in Hormone Replacement Therapy?

  2009cites this paper
• Estrogen therapy affects right hemisphere functioning in postmenopausal women.

  2009cites this paper
• Effets des ligands de PPAR[gamma] sur la voie de signalisation des oestrogènes dans les cellules cancéreuses mammaires

  2009cites this paper
• Development and validation of a liquid chromatographic method for the simultaneous determination of estradiol, estriol, estrone, and progesterone in pharmaceutical preparations.

  2009cites this paper
• Could transdermal estradiol + progesterone be a safer postmenopausal HRT? A review.

  2008cites this paper
• Hormones in wellness and disease prevention: common practices, current state of the evidence, and questions for the future.

  2008cites this paper
• The activities of progesterone receptor isoform A and B are differentially modulated by their ligands in a gene‐selective manner

  2008cites this paper
• ould transdermal estradiol + progesterone be a safer ostmenopausal HRT ? A review

  2008cites this paper
• Human decidual cell Toll-like receptor signaling in response to endotoxin: the effect of progestins.

  2008cites this paper
• eview ould transdermal estradiol + progesterone be a safer ostmenopausal HRT ? A review arc

  2008cites this paper
• Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study

  2008cites this paper
• Differential effects of various progestogens on metabolic risk factors for breast cancer

  2007cites this paper
• Long-term use of progestogens: Colon adenoma and colon carcinoma

  2007cites this paper
• Disruption of androgen receptor signaling by synthetic progestins may increase risk of developing breast cancer

  2007cites this paper
• Novel perspectives for progesterone in hormone replacement therapy, with special reference to the nervous system.

  2007cites this paper
• Progesterone, progestins, pregnancy and breast cancer risk

  2007cites this paper
• Title : Novel perspectives for progesterone in HRT, with special reference to the nervous system

  2007cites this paper
• Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study

  2007cites this paper
• Progesterone: therapeutic opportunities for neuroprotection and myelin repair.

  2007cites this paper
• Phytoestrogens as inhibitors of the human progesterone metabolizing enzyme AKR1C1.

  2006cites this paper